A Phase Ib/II Trial of Ipilimumab-NivolumabDenosumab and Nivolumab-Denosumab in Patients with Unresectable Stage III and IV Melanoma

  • Sandhu, Shahneen (Primary Chief Investigator (PCI))
  • Shackleton, Mark, Melanoma and Skin Cancer Trials Limited (Partner Investigator (PI))
  • Paton, Elizabeth (Supervisor)
  • Williams, Narelle (Project Manager)

Project: Research

Project Details

Short titleMASC 01.15 CHARLI Trial
AcronymMASC 01.15 CHARLI
StatusActive
Effective start/end date24/02/201/06/21